SG Americas Securities’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-237,573
| Closed | -$8.6M | – | 3000 |
|
2025
Q1 | $8.6M | Buy |
237,573
+227,908
| +2,358% | +$8.25M | 0.03% | 311 |
|
2024
Q4 | $407K | Sell |
9,665
-2,648
| -22% | -$112K | ﹤0.01% | 1330 |
|
2024
Q3 | $684K | Sell |
12,313
-3,585
| -23% | -$199K | ﹤0.01% | 1239 |
|
2024
Q2 | $653K | Buy |
+15,898
| New | +$653K | ﹤0.01% | 1400 |
|
2024
Q1 | – | Sell |
-9,199
| Closed | -$440K | – | 2922 |
|
2023
Q4 | $440K | Sell |
9,199
-2,957
| -24% | -$141K | ﹤0.01% | 1411 |
|
2023
Q3 | $433K | Buy |
12,156
+9,677
| +390% | +$345K | 0.01% | 1715 |
|
2023
Q2 | $114K | Sell |
2,479
-22,007
| -90% | -$1.01M | ﹤0.01% | 1783 |
|
2023
Q1 | $982K | Buy |
24,486
+659
| +3% | +$26.4K | 0.01% | 1047 |
|
2022
Q4 | $1.1M | Sell |
23,827
-10,976
| -32% | -$509K | 0.01% | 782 |
|
2022
Q3 | $1.44M | Buy |
34,803
+13,296
| +62% | +$551K | 0.02% | 650 |
|
2022
Q2 | $1.28M | Buy |
21,507
+2,905
| +16% | +$173K | 0.01% | 955 |
|
2022
Q1 | $1.35M | Buy |
18,602
+16,793
| +928% | +$1.22M | 0.01% | 1066 |
|
2021
Q4 | $152K | Sell |
1,809
-185
| -9% | -$15.5K | ﹤0.01% | 2546 |
|
2021
Q3 | $180K | Sell |
1,994
-135,090
| -99% | -$12.2M | ﹤0.01% | 3032 |
|
2021
Q2 | $13.1M | Buy |
137,084
+123,767
| +929% | +$11.8M | 0.06% | 242 |
|
2021
Q1 | $1.52M | Buy |
13,317
+10,087
| +312% | +$1.15M | 0.01% | 1119 |
|
2020
Q4 | $447K | Sell |
3,230
-951
| -23% | -$132K | ﹤0.01% | 1809 |
|
2020
Q3 | $344K | Buy |
4,181
+164
| +4% | +$13.5K | ﹤0.01% | 1561 |
|
2020
Q2 | $314K | Sell |
4,017
-8,981
| -69% | -$702K | ﹤0.01% | 2135 |
|
2020
Q1 | $578K | Sell |
12,998
-2,153
| -14% | -$95.7K | 0.01% | 1405 |
|
2019
Q4 | $647K | Sell |
15,151
-4,310
| -22% | -$184K | 0.01% | 1362 |
|
2019
Q3 | $833K | Buy |
19,461
+12,627
| +185% | +$540K | 0.01% | 1327 |
|
2019
Q2 | $434K | Sell |
6,834
-174,403
| -96% | -$11.1M | ﹤0.01% | 1718 |
|
2019
Q1 | $12.6M | Buy |
181,237
+174,934
| +2,775% | +$12.1M | 0.12% | 153 |
|
2018
Q4 | $274K | Buy |
6,303
+4,803
| +320% | +$209K | ﹤0.01% | 1906 |
|
2018
Q3 | $115K | Sell |
1,500
-1,283
| -46% | -$98.4K | ﹤0.01% | 2450 |
|
2018
Q2 | $214K | Sell |
2,783
-652
| -19% | -$50.1K | ﹤0.01% | 2240 |
|
2018
Q1 | $175K | Buy |
3,435
+315
| +10% | +$16K | ﹤0.01% | 2134 |
|
2017
Q4 | $145K | Buy |
3,120
+191
| +7% | +$8.88K | ﹤0.01% | 2223 |
|
2017
Q3 | $156K | Buy |
+2,929
| New | +$156K | ﹤0.01% | 2451 |
|
2017
Q1 | – | Sell |
-12,520
| Closed | -$880K | – | 2972 |
|
2016
Q4 | $880K | Buy |
12,520
+1,499
| +14% | +$105K | 0.01% | 1249 |
|
2016
Q3 | $782K | Buy |
+11,021
| New | +$782K | 0.01% | 1208 |
|
2016
Q2 | – | Sell |
-5,990
| Closed | -$379K | – | 2412 |
|
2016
Q1 | $379K | Buy |
+5,990
| New | +$379K | ﹤0.01% | 1685 |
|
2015
Q4 | – | Sell |
-4,461
| Closed | -$430K | – | 2408 |
|
2015
Q3 | $430K | Buy |
4,461
+3,037
| +213% | +$293K | ﹤0.01% | 1109 |
|
2015
Q2 | $146K | Sell |
1,424
-2,545
| -64% | -$261K | ﹤0.01% | 1829 |
|
2015
Q1 | $246K | Sell |
3,969
-610
| -13% | -$37.8K | ﹤0.01% | 1559 |
|
2014
Q4 | $201K | Buy |
4,579
+2,149
| +88% | +$94.3K | ﹤0.01% | 2156 |
|
2014
Q3 | $138K | Buy |
+2,430
| New | +$138K | ﹤0.01% | 1901 |
|